New diabetes clinical trial: Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 Diabetes

Published on: October 15, 2023 at 11:00PM
Conditions: Diabetes Mellitus, Type 2
Interventions: Drug: Semaglutide; Drug: Empagliflozin; Drug: Metformin
Sponsors: Novo Nordisk A/S
Not yet recruiting
https://ift.tt/jhmu8JD